79 Meta-analysis and systematic review of coronary vasospasm in ANOCA patients 14. Jansen TPJ, Elias-Smale SE, van den Oord S, Gehlmann H, Dimitiriu-Leen A, Maas A, et al. Sex differences in coronary function test results in patient with angina and nonobstructive disease. Front Cardiovasc Med. (2021) 8:750071. doi: 10.3389/ fcvm.2021.750071 15. Lee DH, Park TK, Seong CS, Gwag HB, Lim AY, Oh MS, et al. Gender differences in long-term clinical outcomes and prognostic factors in patients with vasospastic angina. Int J Cardiol. (2017) 249:6–11. doi: 10.1016/j. ijcard.2017.05.094 16. Mitsugi M, Kaneko H, Yamaki T, Kunii H, Maruyama Y. Correlation between exercise electrocardiography test and coronary flow reserve in patients without organic coronary artery stenosis. J Cardiol. (2007) 49(3):109–14. PMID: 17444136.17444136 17. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, et al. Angina pectoris caused by coronary microvascular spasm. Lancet. (1998) 351(9110):1165–9. doi: 10.1016/S0140-6736(97)07329-7 18. Nishio S, Kusunose K, Yamada H, Hirata Y, Ise T, Yamaguchi K, et al. Echocardiographic epicardial adipose tissue thickness is associated with symptomatic coronary vasospasm during provocative testing. J Am Soc Echocardiogr. (2017) 30(10):1021–7. e1. doi: 10.1016/j.echo.2017.06.024 19. Odaka Y, Takahashi J, Tsuburaya R, Nishimiya K, Hao K, Matsumoto Y, et al. Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries. Eur Heart J. (2017) 38(7):489–96. doi: 10.1093/eurheartj/ehw448 20. Schoenenberger AW, Adler E, Gujer S, Jamshidi P, Kobza R, Stuck AE, et al. Prognostic value of an abnormal response to acetylcholine in patients with angina and non-obstructive coronary artery disease: long-term follow-up of the heart quest cohort. Int J Cardiol. (2016) 221:539–45. doi: 10.1016/j.ijcard.2016.07.035 21. Scholl JM, Benacerraf A, Ducimetiere P, Chabas D, Brau J, Chapelle J, et al. Comparison of risk factors in vasospastic angina without significant fixed coronary narrowing to significant fixed coronary narrowing and no vasospastic angina. Am J Cardiol. (1986) 57(4):199–202. doi: 10.1016/0002-9149(86)90890-8 22. Sheikh AR, Zeitz CJ, Rajendran S, Di Fiore DP, Tavella R, Beltrame JF. Clinical and coronary haemodynamic determinants of recurrent chest pain in patients without obstructive coronary artery disease—a pilot study. Int J Cardiol. (2018) 267:16–21. doi: 10.1016/j.ijcard.2018.04.077 23. Suda A, Takahashi J, Hao K, Kikuchi Y, Shindo T, Ikeda S, et al. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease. J Am Coll Cardiol. (2019) 74(19):2350–60. doi: 10.1016/j.jacc.2019.08.1056 24. Sun H, Fukumoto Y, Ito A, Shimokawa H, Sunagawa K. Coronary microvascular dysfunction in patients with microvascular angina: analysis by TIMI frame count. J Cardiovasc Pharmacol. (2005) 46(5):622– 6. doi: 10.1097/01.fjc.0000181291.96086.ae 25. Yamanaga K, Tsujita K, Komura N, Kaikita K, Sakamoto K, Miyazaki T, et al. Single-wire pressure and flow velocity measurement for quantifying microvascular dysfunction in patients with coronary vasospastic angina. Am J Physiol Heart Circ Physiol. (2015) 308(5):H478–84. doi: 10.1152/ ajpheart.00593.2014 26. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries—longterm follow-up of 277 patients. Eur Heart J. (1996) 17(7):1015–21. doi: 10.1093/ oxfordjournals.eurheartj.a014996 4
RkJQdWJsaXNoZXIy MTk4NDMw